Cargando…

Recombinant Measles AIK-C Vaccine Strain Expressing Influenza HA Protein

Recombinant measles AIK-C vaccine expressing the hemagglutinin (HA) protein of influenza A/Sapporo/107/2013(H1N1pdm) (MVAIK/PdmHA) was constructed. Measles particle agglutination (PA) and influenza hemagglutinin inhibition (HI) antibodies were induced in cotton rats immunized with MVAIK/PdmHA. Cotto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Takashi, Kumagai, Takuji, Yamaji, Yoshiaki, Sawada, Akihito, Nakayama, Tetsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349030/ https://www.ncbi.nlm.nih.gov/pubmed/32230902 http://dx.doi.org/10.3390/vaccines8020149

Ejemplares similares

Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens
por: Nakayama, Tetsuo, et al.
Publicado: (2016)

AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats
por: Sawada, Akihito, et al.
Publicado: (2011)

Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus
por: Higuchi, Akira, et al.
Publicado: (2016)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
por: Sawada, Akihito, et al.
Publicado: (2021)

Simultaneous Administration of Recombinant Measles Viruses Expressing Respiratory Syncytial Virus Fusion (F) and Nucleo (N) Proteins Induced Humoral and Cellular Immune Responses in Cotton Rats
por: Yamaji, Yoshiaki, et al.
Publicado: (2019)

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial
por: Nakayama, Tetsuo, et al.
Publicado: (2019)

Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice
por: Nakayama, Tetsuo, et al.
Publicado: (2022)

Athéisme et sécularisme au Kenya : les tribulations des Atheists In Kenya (AIK)
por: Maupeu, Hervé, et al.
Publicado: (2022)

Evidence of recombination among early-vaccination era measles virus strains
por: Schierup, Mikkel H, et al.
Publicado: (2005)

Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017)

Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009)

Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults
por: Fadlyana, Eddy, et al.
Publicado: (2023)

Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016)

High prevalence of IgE sensitization to inactivated influenza vaccines, yet robust IgG4 responses, in a healthy pediatric population
por: Tonto, Prince Baffour, et al.
Publicado: (2022)

Prospects of HA-Based Universal Influenza Vaccine
por: Hashem, Anwar M.
Publicado: (2015)

Strain-independent inactivated influenza vaccine production by removal of the hemagglutinin heavy HA1 chain
Publicado: (1986)

93. Novel recombinant measles virus vaccine prevents measles virus disease in rhesus macaques
por: Rubens, Jessica, et al.
Publicado: (2022)

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
por: Li, Athena P. Y., et al.
Publicado: (2021)

Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats
por: Yamaji, Yoshiaki, et al.
Publicado: (2016)

Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
por: Myers, Mallory L., et al.
Publicado: (2023)

A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity
por: Julik, Emily, et al.
Publicado: (2017)

Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines
por: Kashiwagi, Yasuyo, et al.
Publicado: (2014)

Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains
por: Dong, Chunhong, et al.
Publicado: (2021)

Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
por: Tsybalova, Liudmila M., et al.
Publicado: (2018)

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
por: Wang, Jiong, et al.
Publicado: (2018)

Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
por: Ebenig, Aileen, et al.
Publicado: (2022)

Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models
por: Saito, Makoto, et al.
Publicado: (2021)

Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012)

Stalking influenza by vaccination with pre-fusion headless HA mini-stem
por: Valkenburg, Sophie A., et al.
Publicado: (2016)

Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines
por: Lin, Shih-Chang, et al.
Publicado: (2011)

Notes on the Epidemiology of Measles and Influenza
por: Crerar, J. W.
Publicado: (1921)

Immunogenicity of a Recombinant Measles-HIV-1 Clade B Candidate Vaccine
por: Stebbings, Richard, et al.
Publicado: (2012)

Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan
por: Matsumura, Takayo, et al.
Publicado: (2005)

Novel clinical features of recurrent human respiratory syncytial virus infections
por: Yui, Ikuko, et al.
Publicado: (2014)

Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea
por: Kim, Jin Il, et al.
Publicado: (2017)

Recombinant Vectors as Influenza Vaccines
por: Kopecky-Bromberg, Sarah A., et al.
Publicado: (2009)

Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans
por: Richards, K. A., et al.
Publicado: (2020)

Influenza, Measles, SARS, MERS, and Smallpox
por: Chertow, Daniel S., et al.
Publicado: (2020)

Influence of measles-mumps-rubella vaccine series initiation and completion on influenza vaccination among adolescents
por: Beeninga, F. Trent, et al.
Publicado: (2022)

Mass Measles Vaccination
por: Ghorbani, Gholam Ali
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qjurha8c68nep01d16hbim2nmp